Agilon Health (NYSE:AGL) Shares Up 3.3% – Should You Buy?

Agilon Health, Inc. (NYSE:AGL) shot up 3.3% during trading on Wednesday. The company traded as high as $85.81 and last traded at $86.1120. Approximately 16,983 shares changed hands during mid-day trading, a decline of 95% from the average daily volume of 331,238 shares. The stock had previously closed at $83.40.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on AGL shares. Royal Bank Of Canada set a $125.00 target price on Agilon Health in a report on Tuesday, September 15th. Truist Financial set a $112.00 price target on shares of Agilon Health and gave the stock a “hold” rating in a research report on Thursday, August 6th. Barclays set a $111.00 price objective on shares of Agilon Health and gave the stock an “equal weight” rating in a research note on Thursday, August 6th. Wells Fargo & Company reissued an “overweight” rating and issued a $146.00 price objective (up from $141.00) on shares of Agilon Health in a report on Tuesday, August 11th. Finally, JPMorgan Chase & Co. raised their target price on shares of Agilon Health from $31.00 to $85.00 and gave the stock an “underweight” rating in a report on Monday, August 24th. Six analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have given a Sell rating to the company. According to MarketBeat, Agilon Health has a consensus rating of “Hold” and an average price target of $102.25.

Agilon Health Stock Up 3.2%

The firm has a 50 day simple moving average of $89.89 and a two-hundred day simple moving average of $77.85. The stock has a market capitalization of $1.44 billion, a P/E ratio of -6.07 and a beta of 2.98. The company has a quick ratio of 1.08, a current ratio of 1.08 and a debt-to-equity ratio of 0.07.

Agilon Health (NYSE:AGL) last posted its quarterly earnings results on Wednesday, August 5th. The company reported $1.04 EPS for the quarter, topping analysts’ consensus estimates of $0.14 by $0.90. Agilon Health had a negative return on equity of 119.38% and a negative net margin of 3.92%.The company had revenue of $1.49 billion during the quarter, compared to analysts’ expectations of $1.45 billion. On average, equities research analysts expect that Agilon Health, Inc. will post -2.9 earnings per share for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of the business. State Street Corp bought a new position in shares of Agilon Health in the second quarter worth about $30,024,000. The Manufacturers Life Insurance Company acquired a new position in Agilon Health during the 2nd quarter worth approximately $355,000. Tidal Investments LLC acquired a new position in Agilon Health during the 2nd quarter worth approximately $1,405,000. Engineers Gate Manager LP bought a new position in Agilon Health in the 2nd quarter valued at approximately $516,000. Finally, Integrated Wealth Concepts LLC bought a new position in Agilon Health in the 2nd quarter valued at approximately $384,000.

About Agilon Health

Agilon Health, Inc is a healthcare company that helps primary care physicians transition from traditional fee-for-service medicine to value-based care. The company primarily works with independent physician practices that serve older adults, particularly Medicare Advantage members, with the goal of improving care coordination, patient outcomes and the overall healthcare experience.

Agilon provides a technology and services platform designed to support population health management. Its offerings include data analytics, clinical and administrative workflows, practice management support, care coordination resources and assistance with payer contracting.